nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—KCNMA1—pulmonary artery—lung cancer	0.0709	0.31	CbGeAlD
Bendroflumethiazide—Hepatic encephalopathy—Paclitaxel—lung cancer	0.0251	0.0501	CcSEcCtD
Bendroflumethiazide—Hypotensive—Teniposide—lung cancer	0.0234	0.0467	CcSEcCtD
Bendroflumethiazide—SLC12A3—respiratory system—lung cancer	0.0172	0.0754	CbGeAlD
Bendroflumethiazide—Drug interaction—Gefitinib—lung cancer	0.0113	0.0226	CcSEcCtD
Bendroflumethiazide—Hypotensive—Paclitaxel—lung cancer	0.00999	0.0199	CcSEcCtD
Bendroflumethiazide—KCNMA1—epithelium—lung cancer	0.00996	0.0436	CbGeAlD
Bendroflumethiazide—SLC12A3—lung—lung cancer	0.00915	0.04	CbGeAlD
Bendroflumethiazide—CA1—respiratory system—lung cancer	0.00906	0.0396	CbGeAlD
Bendroflumethiazide—TPMT—cardiac atrium—lung cancer	0.0089	0.0389	CbGeAlD
Bendroflumethiazide—Hypokalaemia—Crizotinib—lung cancer	0.00763	0.0152	CcSEcCtD
Bendroflumethiazide—TPMT—bone marrow—lung cancer	0.00751	0.0328	CbGeAlD
Bendroflumethiazide—CA4—respiratory system—lung cancer	0.00708	0.031	CbGeAlD
Bendroflumethiazide—Allergic cutaneous angiitis—Methotrexate—lung cancer	0.007	0.014	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Gefitinib—lung cancer	0.00693	0.0138	CcSEcCtD
Bendroflumethiazide—TPMT—lung—lung cancer	0.0068	0.0298	CbGeAlD
Bendroflumethiazide—Drug interaction—Erlotinib—lung cancer	0.00676	0.0135	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Pemetrexed—lung cancer	0.00649	0.013	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Gefitinib—lung cancer	0.00645	0.0129	CcSEcCtD
Bendroflumethiazide—KCNMA1—lung—lung cancer	0.00633	0.0277	CbGeAlD
Bendroflumethiazide—CA2—respiratory system—lung cancer	0.00587	0.0257	CbGeAlD
Bendroflumethiazide—CA1—bone marrow—lung cancer	0.00531	0.0232	CbGeAlD
Bendroflumethiazide—CA4—trachea—lung cancer	0.00523	0.0229	CbGeAlD
Bendroflumethiazide—CA4—cardiac atrium—lung cancer	0.00491	0.0215	CbGeAlD
Bendroflumethiazide—CA2—epithelium—lung cancer	0.00491	0.0215	CbGeAlD
Bendroflumethiazide—CA2—bronchus—lung cancer	0.00483	0.0211	CbGeAlD
Bendroflumethiazide—CA1—lung—lung cancer	0.00481	0.021	CbGeAlD
Bendroflumethiazide—Drug interaction—Gemcitabine—lung cancer	0.00469	0.00936	CcSEcCtD
Bendroflumethiazide—TPMT—lymph node—lung cancer	0.00465	0.0204	CbGeAlD
Bendroflumethiazide—Leukocytoclastic vasculitis—Methotrexate—lung cancer	0.00454	0.00906	CcSEcCtD
Bendroflumethiazide—Polyuria—Vinorelbine—lung cancer	0.00448	0.00894	CcSEcCtD
Bendroflumethiazide—Blood disorder—Paclitaxel—lung cancer	0.00436	0.00871	CcSEcCtD
Bendroflumethiazide—CA2—trachea—lung cancer	0.00434	0.019	CbGeAlD
Bendroflumethiazide—KCNMA1—lymph node—lung cancer	0.00433	0.0189	CbGeAlD
Bendroflumethiazide—CA4—bone marrow—lung cancer	0.00415	0.0181	CbGeAlD
Bendroflumethiazide—Cramp muscle—Topotecan—lung cancer	0.00414	0.00826	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Erlotinib—lung cancer	0.00414	0.00826	CcSEcCtD
Bendroflumethiazide—CA2—cardiac atrium—lung cancer	0.00407	0.0178	CbGeAlD
Bendroflumethiazide—Drug interaction—Paclitaxel—lung cancer	0.00393	0.00784	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Erlotinib—lung cancer	0.00386	0.00769	CcSEcCtD
Bendroflumethiazide—CA4—lung—lung cancer	0.00376	0.0164	CbGeAlD
Bendroflumethiazide—Thrombocytopenia—Pemetrexed—lung cancer	0.00369	0.00735	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Gefitinib—lung cancer	0.00366	0.00731	CcSEcCtD
Bendroflumethiazide—Anorexia—Pemetrexed—lung cancer	0.00359	0.00716	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Crizotinib—lung cancer	0.00358	0.00714	CcSEcCtD
Bendroflumethiazide—Anorexia—Gefitinib—lung cancer	0.00357	0.00711	CcSEcCtD
Bendroflumethiazide—Constipation—Crizotinib—lung cancer	0.00352	0.00703	CcSEcCtD
Bendroflumethiazide—Hypotension—Gefitinib—lung cancer	0.0035	0.00697	CcSEcCtD
Bendroflumethiazide—CA2—bone marrow—lung cancer	0.00344	0.015	CbGeAlD
Bendroflumethiazide—Polyuria—Cisplatin—lung cancer	0.00335	0.00669	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Vinorelbine—lung cancer	0.00333	0.00665	CcSEcCtD
Bendroflumethiazide—Drug interaction—Docetaxel—lung cancer	0.00333	0.00665	CcSEcCtD
Bendroflumethiazide—Urine output increased—Paclitaxel—lung cancer	0.0033	0.00658	CcSEcCtD
Bendroflumethiazide—CA1—lymph node—lung cancer	0.00329	0.0144	CbGeAlD
Bendroflumethiazide—Decreased appetite—Pemetrexed—lung cancer	0.00327	0.00653	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Gefitinib—lung cancer	0.00325	0.00649	CcSEcCtD
Bendroflumethiazide—Constipation—Pemetrexed—lung cancer	0.00322	0.00642	CcSEcCtD
Bendroflumethiazide—Constipation—Gefitinib—lung cancer	0.0032	0.00638	CcSEcCtD
Bendroflumethiazide—CA2—lung—lung cancer	0.00312	0.0136	CbGeAlD
Bendroflumethiazide—Polyuria—Paclitaxel—lung cancer	0.00301	0.00601	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Teniposide—lung cancer	0.00299	0.00596	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Irinotecan—lung cancer	0.00296	0.00591	CcSEcCtD
Bendroflumethiazide—Asthenia—Crizotinib—lung cancer	0.00296	0.0059	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Irinotecan—lung cancer	0.00295	0.00589	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Irinotecan—lung cancer	0.00292	0.00583	CcSEcCtD
Bendroflumethiazide—Anorexia—Teniposide—lung cancer	0.00291	0.0058	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Gemcitabine—lung cancer	0.00288	0.00574	CcSEcCtD
Bendroflumethiazide—Hypotension—Teniposide—lung cancer	0.00285	0.00569	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Crizotinib—lung cancer	0.00282	0.00562	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Irinotecan—lung cancer	0.00275	0.00549	CcSEcCtD
Bendroflumethiazide—Dizziness—Crizotinib—lung cancer	0.00272	0.00544	CcSEcCtD
Bendroflumethiazide—Asthenia—Pemetrexed—lung cancer	0.0027	0.00539	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Cisplatin—lung cancer	0.00269	0.00537	CcSEcCtD
Bendroflumethiazide—Asthenia—Gefitinib—lung cancer	0.00268	0.00535	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Cisplatin—lung cancer	0.00268	0.00535	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Topotecan—lung cancer	0.00266	0.00531	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Cisplatin—lung cancer	0.00265	0.00529	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Teniposide—lung cancer	0.00265	0.00529	CcSEcCtD
Bendroflumethiazide—Vomiting—Crizotinib—lung cancer	0.00262	0.00523	CcSEcCtD
Bendroflumethiazide—Rash—Crizotinib—lung cancer	0.0026	0.00518	CcSEcCtD
Bendroflumethiazide—Dermatitis—Crizotinib—lung cancer	0.0026	0.00518	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Pemetrexed—lung cancer	0.00258	0.00514	CcSEcCtD
Bendroflumethiazide—CA4—lymph node—lung cancer	0.00257	0.0112	CbGeAlD
Bendroflumethiazide—Diarrhoea—Gefitinib—lung cancer	0.00256	0.00511	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Cisplatin—lung cancer	0.0025	0.00498	CcSEcCtD
Bendroflumethiazide—Dizziness—Pemetrexed—lung cancer	0.00249	0.00497	CcSEcCtD
Bendroflumethiazide—Nausea—Crizotinib—lung cancer	0.00245	0.00488	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Etoposide—lung cancer	0.00243	0.00485	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Paclitaxel—lung cancer	0.00242	0.00482	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Paclitaxel—lung cancer	0.00241	0.0048	CcSEcCtD
Bendroflumethiazide—Vomiting—Pemetrexed—lung cancer	0.00239	0.00478	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Paclitaxel—lung cancer	0.00238	0.00475	CcSEcCtD
Bendroflumethiazide—Vomiting—Gefitinib—lung cancer	0.00238	0.00475	CcSEcCtD
Bendroflumethiazide—Rash—Pemetrexed—lung cancer	0.00237	0.00474	CcSEcCtD
Bendroflumethiazide—Dermatitis—Pemetrexed—lung cancer	0.00237	0.00473	CcSEcCtD
Bendroflumethiazide—Rash—Gefitinib—lung cancer	0.00236	0.00471	CcSEcCtD
Bendroflumethiazide—Dermatitis—Gefitinib—lung cancer	0.00236	0.0047	CcSEcCtD
Bendroflumethiazide—Blood disorder—Doxorubicin—lung cancer	0.00231	0.00461	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Vinblastine—lung cancer	0.00228	0.00455	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Paclitaxel—lung cancer	0.00224	0.00447	CcSEcCtD
Bendroflumethiazide—Nausea—Pemetrexed—lung cancer	0.00224	0.00446	CcSEcCtD
Bendroflumethiazide—Nausea—Gefitinib—lung cancer	0.00222	0.00443	CcSEcCtD
Bendroflumethiazide—Anorexia—Vinblastine—lung cancer	0.00222	0.00442	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Topotecan—lung cancer	0.00221	0.00442	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Erlotinib—lung cancer	0.00219	0.00437	CcSEcCtD
Bendroflumethiazide—Asthenia—Teniposide—lung cancer	0.00219	0.00437	CcSEcCtD
Bendroflumethiazide—Anorexia—Topotecan—lung cancer	0.00215	0.0043	CcSEcCtD
Bendroflumethiazide—CA2—lymph node—lung cancer	0.00213	0.00932	CbGeAlD
Bendroflumethiazide—Anorexia—Erlotinib—lung cancer	0.00213	0.00425	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Teniposide—lung cancer	0.00209	0.00416	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Docetaxel—lung cancer	0.00205	0.00409	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Vinblastine—lung cancer	0.00202	0.00404	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Docetaxel—lung cancer	0.00202	0.00403	CcSEcCtD
Bendroflumethiazide—Urine output increased—Methotrexate—lung cancer	0.00201	0.00402	CcSEcCtD
Bendroflumethiazide—Constipation—Vinblastine—lung cancer	0.00199	0.00397	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Topotecan—lung cancer	0.00196	0.00392	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Erlotinib—lung cancer	0.00194	0.00388	CcSEcCtD
Bendroflumethiazide—Vomiting—Teniposide—lung cancer	0.00194	0.00387	CcSEcCtD
Bendroflumethiazide—Constipation—Topotecan—lung cancer	0.00193	0.00386	CcSEcCtD
Bendroflumethiazide—Rash—Teniposide—lung cancer	0.00192	0.00384	CcSEcCtD
Bendroflumethiazide—Dermatitis—Teniposide—lung cancer	0.00192	0.00383	CcSEcCtD
Bendroflumethiazide—Constipation—Erlotinib—lung cancer	0.00191	0.00382	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Vinorelbine—lung cancer	0.00189	0.00378	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Irinotecan—lung cancer	0.00188	0.00375	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Methotrexate—lung cancer	0.00186	0.00371	CcSEcCtD
Bendroflumethiazide—Anorexia—Vinorelbine—lung cancer	0.00184	0.00368	CcSEcCtD
Bendroflumethiazide—Polyuria—Methotrexate—lung cancer	0.00184	0.00367	CcSEcCtD
Bendroflumethiazide—Nausea—Teniposide—lung cancer	0.00181	0.00361	CcSEcCtD
Bendroflumethiazide—Hypotension—Vinorelbine—lung cancer	0.00181	0.0036	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Cisplatin—lung cancer	0.00171	0.0034	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Vinorelbine—lung cancer	0.00168	0.00335	CcSEcCtD
Bendroflumethiazide—Asthenia—Vinblastine—lung cancer	0.00167	0.00333	CcSEcCtD
Bendroflumethiazide—Constipation—Vinorelbine—lung cancer	0.00165	0.0033	CcSEcCtD
Bendroflumethiazide—Asthenia—Topotecan—lung cancer	0.00162	0.00324	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Doxorubicin—lung cancer	0.00161	0.00321	CcSEcCtD
Bendroflumethiazide—Asthenia—Erlotinib—lung cancer	0.0016	0.0032	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Vinblastine—lung cancer	0.00159	0.00318	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Doxorubicin—lung cancer	0.00156	0.00312	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Etoposide—lung cancer	0.00156	0.00312	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Irinotecan—lung cancer	0.00156	0.00312	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Topotecan—lung cancer	0.00155	0.00309	CcSEcCtD
Bendroflumethiazide—Dizziness—Vinblastine—lung cancer	0.00154	0.00307	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Paclitaxel—lung cancer	0.00153	0.00306	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Erlotinib—lung cancer	0.00153	0.00305	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Gemcitabine—lung cancer	0.00152	0.00303	CcSEcCtD
Bendroflumethiazide—Anorexia—Irinotecan—lung cancer	0.00152	0.00303	CcSEcCtD
Bendroflumethiazide—Dizziness—Topotecan—lung cancer	0.00149	0.00298	CcSEcCtD
Bendroflumethiazide—Hypotension—Irinotecan—lung cancer	0.00149	0.00297	CcSEcCtD
Bendroflumethiazide—Anorexia—Gemcitabine—lung cancer	0.00148	0.00295	CcSEcCtD
Bendroflumethiazide—Vomiting—Vinblastine—lung cancer	0.00148	0.00295	CcSEcCtD
Bendroflumethiazide—Dizziness—Erlotinib—lung cancer	0.00148	0.00295	CcSEcCtD
Bendroflumethiazide—Purpura—Doxorubicin—lung cancer	0.00145	0.0029	CcSEcCtD
Bendroflumethiazide—Hypotension—Gemcitabine—lung cancer	0.00145	0.0029	CcSEcCtD
Bendroflumethiazide—Vomiting—Topotecan—lung cancer	0.00144	0.00287	CcSEcCtD
Bendroflumethiazide—Rash—Topotecan—lung cancer	0.00143	0.00284	CcSEcCtD
Bendroflumethiazide—Dermatitis—Topotecan—lung cancer	0.00142	0.00284	CcSEcCtD
Bendroflumethiazide—Vomiting—Erlotinib—lung cancer	0.00142	0.00284	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Cisplatin—lung cancer	0.00142	0.00283	CcSEcCtD
Bendroflumethiazide—Rash—Erlotinib—lung cancer	0.00141	0.00281	CcSEcCtD
Bendroflumethiazide—Dermatitis—Erlotinib—lung cancer	0.00141	0.00281	CcSEcCtD
Bendroflumethiazide—Asthenia—Vinorelbine—lung cancer	0.00139	0.00277	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Irinotecan—lung cancer	0.00139	0.00277	CcSEcCtD
Bendroflumethiazide—Nausea—Vinblastine—lung cancer	0.00138	0.00276	CcSEcCtD
Bendroflumethiazide—Anorexia—Cisplatin—lung cancer	0.00138	0.00275	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Methotrexate—lung cancer	0.00137	0.00273	CcSEcCtD
Bendroflumethiazide—Constipation—Irinotecan—lung cancer	0.00136	0.00272	CcSEcCtD
Bendroflumethiazide—Hypotension—Cisplatin—lung cancer	0.00135	0.0027	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Gemcitabine—lung cancer	0.00135	0.00269	CcSEcCtD
Bendroflumethiazide—Nausea—Topotecan—lung cancer	0.00134	0.00268	CcSEcCtD
Bendroflumethiazide—Constipation—Gemcitabine—lung cancer	0.00133	0.00265	CcSEcCtD
Bendroflumethiazide—Nausea—Erlotinib—lung cancer	0.00133	0.00265	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Vinorelbine—lung cancer	0.00132	0.00264	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Etoposide—lung cancer	0.0013	0.00259	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Docetaxel—lung cancer	0.0013	0.00259	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Methotrexate—lung cancer	0.00129	0.00257	CcSEcCtD
Bendroflumethiazide—Dizziness—Vinorelbine—lung cancer	0.00128	0.00255	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Doxorubicin—lung cancer	0.00128	0.00255	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Doxorubicin—lung cancer	0.00127	0.00254	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Paclitaxel—lung cancer	0.00127	0.00254	CcSEcCtD
Bendroflumethiazide—Anorexia—Etoposide—lung cancer	0.00126	0.00252	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Cisplatin—lung cancer	0.00126	0.00251	CcSEcCtD
Bendroflumethiazide—Anorexia—Paclitaxel—lung cancer	0.00124	0.00247	CcSEcCtD
Bendroflumethiazide—Hypotension—Etoposide—lung cancer	0.00124	0.00247	CcSEcCtD
Bendroflumethiazide—Vomiting—Vinorelbine—lung cancer	0.00123	0.00245	CcSEcCtD
Bendroflumethiazide—Rash—Vinorelbine—lung cancer	0.00122	0.00243	CcSEcCtD
Bendroflumethiazide—Dermatitis—Vinorelbine—lung cancer	0.00122	0.00243	CcSEcCtD
Bendroflumethiazide—Hypotension—Paclitaxel—lung cancer	0.00122	0.00242	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Doxorubicin—lung cancer	0.00119	0.00237	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Etoposide—lung cancer	0.00115	0.0023	CcSEcCtD
Bendroflumethiazide—Nausea—Vinorelbine—lung cancer	0.00115	0.00229	CcSEcCtD
Bendroflumethiazide—Asthenia—Irinotecan—lung cancer	0.00114	0.00228	CcSEcCtD
Bendroflumethiazide—Constipation—Etoposide—lung cancer	0.00113	0.00226	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Paclitaxel—lung cancer	0.00113	0.00226	CcSEcCtD
Bendroflumethiazide—Asthenia—Gemcitabine—lung cancer	0.00111	0.00222	CcSEcCtD
Bendroflumethiazide—Constipation—Paclitaxel—lung cancer	0.00111	0.00222	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Irinotecan—lung cancer	0.00109	0.00218	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Docetaxel—lung cancer	0.00108	0.00215	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Gemcitabine—lung cancer	0.00106	0.00212	CcSEcCtD
Bendroflumethiazide—Dizziness—Irinotecan—lung cancer	0.00105	0.0021	CcSEcCtD
Bendroflumethiazide—Anorexia—Docetaxel—lung cancer	0.00105	0.0021	CcSEcCtD
Bendroflumethiazide—Asthenia—Cisplatin—lung cancer	0.00104	0.00207	CcSEcCtD
Bendroflumethiazide—Hypotension—Docetaxel—lung cancer	0.00103	0.00206	CcSEcCtD
Bendroflumethiazide—Vomiting—Irinotecan—lung cancer	0.00101	0.00202	CcSEcCtD
Bendroflumethiazide—Rash—Irinotecan—lung cancer	0.00101	0.00201	CcSEcCtD
Bendroflumethiazide—Dermatitis—Irinotecan—lung cancer	0.001	0.002	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Cisplatin—lung cancer	0.000991	0.00198	CcSEcCtD
Bendroflumethiazide—Vomiting—Gemcitabine—lung cancer	0.000988	0.00197	CcSEcCtD
Bendroflumethiazide—Rash—Gemcitabine—lung cancer	0.000979	0.00195	CcSEcCtD
Bendroflumethiazide—Dermatitis—Gemcitabine—lung cancer	0.000978	0.00195	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Docetaxel—lung cancer	0.000958	0.00191	CcSEcCtD
Bendroflumethiazide—Asthenia—Etoposide—lung cancer	0.000952	0.0019	CcSEcCtD
Bendroflumethiazide—Nausea—Irinotecan—lung cancer	0.000947	0.00189	CcSEcCtD
Bendroflumethiazide—Constipation—Docetaxel—lung cancer	0.000943	0.00188	CcSEcCtD
Bendroflumethiazide—Asthenia—Paclitaxel—lung cancer	0.000933	0.00186	CcSEcCtD
Bendroflumethiazide—Nausea—Gemcitabine—lung cancer	0.000923	0.00184	CcSEcCtD
Bendroflumethiazide—Vomiting—Cisplatin—lung cancer	0.000921	0.00184	CcSEcCtD
Bendroflumethiazide—Rash—Cisplatin—lung cancer	0.000913	0.00182	CcSEcCtD
Bendroflumethiazide—Dermatitis—Cisplatin—lung cancer	0.000912	0.00182	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Etoposide—lung cancer	0.000908	0.00181	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Paclitaxel—lung cancer	0.00089	0.00178	CcSEcCtD
Bendroflumethiazide—Dizziness—Etoposide—lung cancer	0.000877	0.00175	CcSEcCtD
Bendroflumethiazide—Dizziness—Paclitaxel—lung cancer	0.00086	0.00172	CcSEcCtD
Bendroflumethiazide—Nausea—Cisplatin—lung cancer	0.00086	0.00172	CcSEcCtD
Bendroflumethiazide—Vomiting—Etoposide—lung cancer	0.000843	0.00168	CcSEcCtD
Bendroflumethiazide—Rash—Etoposide—lung cancer	0.000836	0.00167	CcSEcCtD
Bendroflumethiazide—Dermatitis—Etoposide—lung cancer	0.000836	0.00167	CcSEcCtD
Bendroflumethiazide—Vomiting—Paclitaxel—lung cancer	0.000827	0.00165	CcSEcCtD
Bendroflumethiazide—Rash—Paclitaxel—lung cancer	0.00082	0.00164	CcSEcCtD
Bendroflumethiazide—Dermatitis—Paclitaxel—lung cancer	0.000819	0.00163	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Doxorubicin—lung cancer	0.00081	0.00162	CcSEcCtD
Bendroflumethiazide—Asthenia—Docetaxel—lung cancer	0.000791	0.00158	CcSEcCtD
Bendroflumethiazide—Nausea—Etoposide—lung cancer	0.000788	0.00157	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Methotrexate—lung cancer	0.000778	0.00155	CcSEcCtD
Bendroflumethiazide—Nausea—Paclitaxel—lung cancer	0.000772	0.00154	CcSEcCtD
Bendroflumethiazide—Anorexia—Methotrexate—lung cancer	0.000757	0.00151	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Docetaxel—lung cancer	0.000754	0.0015	CcSEcCtD
Bendroflumethiazide—Hypotension—Methotrexate—lung cancer	0.000742	0.00148	CcSEcCtD
Bendroflumethiazide—Dizziness—Docetaxel—lung cancer	0.000729	0.00145	CcSEcCtD
Bendroflumethiazide—Vomiting—Docetaxel—lung cancer	0.000701	0.0014	CcSEcCtD
Bendroflumethiazide—Rash—Docetaxel—lung cancer	0.000695	0.00139	CcSEcCtD
Bendroflumethiazide—Dermatitis—Docetaxel—lung cancer	0.000694	0.00139	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Methotrexate—lung cancer	0.000691	0.00138	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Doxorubicin—lung cancer	0.000674	0.00134	CcSEcCtD
Bendroflumethiazide—Anorexia—Doxorubicin—lung cancer	0.000656	0.00131	CcSEcCtD
Bendroflumethiazide—Nausea—Docetaxel—lung cancer	0.000655	0.00131	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000648	0.0024	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000648	0.0024	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IRF1—lung cancer	0.000645	0.00239	CbGpPWpGaD
Bendroflumethiazide—Hypotension—Doxorubicin—lung cancer	0.000643	0.00128	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—ATP5H—lung cancer	0.00063	0.00233	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MTMR3—lung cancer	0.00063	0.00233	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—MYC—lung cancer	0.000618	0.00229	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PGAM1—lung cancer	0.000614	0.00227	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ATP5H—lung cancer	0.000604	0.00224	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—TF—lung cancer	0.000602	0.00223	CbGpPWpGaD
Bendroflumethiazide—Decreased appetite—Doxorubicin—lung cancer	0.000598	0.00119	CcSEcCtD
Bendroflumethiazide—Constipation—Doxorubicin—lung cancer	0.000588	0.00117	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—APP—lung cancer	0.000588	0.00218	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PLBD1—lung cancer	0.000586	0.00217	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2A7—lung cancer	0.000586	0.00217	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SDC4—lung cancer	0.000574	0.00212	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—KRAS—lung cancer	0.000571	0.00211	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Methotrexate—lung cancer	0.00057	0.00114	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—PLBD1—lung cancer	0.000562	0.00208	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Methotrexate—lung cancer	0.000544	0.00108	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—PLBD1—lung cancer	0.000539	0.00199	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HSD17B10—lung cancer	0.000536	0.00198	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Methotrexate—lung cancer	0.000525	0.00105	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—RRM1—lung cancer	0.000522	0.00193	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTA3—lung cancer	0.000522	0.00193	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HSD17B10—lung cancer	0.000514	0.0019	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Methotrexate—lung cancer	0.000505	0.00101	CcSEcCtD
Bendroflumethiazide—Rash—Methotrexate—lung cancer	0.000501	0.000999	CcSEcCtD
Bendroflumethiazide—Dermatitis—Methotrexate—lung cancer	0.0005	0.000999	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—CKB—lung cancer	0.000498	0.00184	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—ALB—lung cancer	0.000498	0.00184	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Doxorubicin—lung cancer	0.000494	0.000985	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—HSD17B10—lung cancer	0.000493	0.00182	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—B4GALT5—lung cancer	0.000491	0.00182	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—HRAS—lung cancer	0.000485	0.0018	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—BRAF—lung cancer	0.000483	0.00179	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CKB—lung cancer	0.000478	0.00177	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTA4—lung cancer	0.000478	0.00177	CbGpPWpGaD
Bendroflumethiazide—Nausea—Methotrexate—lung cancer	0.000472	0.000942	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Doxorubicin—lung cancer	0.000471	0.000939	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—ITGB1—lung cancer	0.00047	0.00174	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CNDP2—lung cancer	0.000469	0.00173	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTM2—lung cancer	0.000469	0.00173	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTA2—lung cancer	0.000466	0.00172	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CKB—lung cancer	0.000458	0.0017	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—JUN—lung cancer	0.000457	0.00169	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTMR3—lung cancer	0.000456	0.00169	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Doxorubicin—lung cancer	0.000455	0.000908	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—CNDP2—lung cancer	0.000449	0.00166	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTM2—lung cancer	0.000449	0.00166	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTA1—lung cancer	0.000449	0.00166	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PGAM1—lung cancer	0.000444	0.00164	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ABCC3—lung cancer	0.000444	0.00164	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—PTEN—lung cancer	0.000442	0.00164	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Doxorubicin—lung cancer	0.000437	0.000873	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—MTMR3—lung cancer	0.000437	0.00162	CbGpPWpGaD
Bendroflumethiazide—Rash—Doxorubicin—lung cancer	0.000434	0.000865	CcSEcCtD
Bendroflumethiazide—Dermatitis—Doxorubicin—lung cancer	0.000433	0.000865	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—GSTM2—lung cancer	0.000431	0.00159	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CNDP2—lung cancer	0.000431	0.00159	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AKR1C1—lung cancer	0.00043	0.00159	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PGAM1—lung cancer	0.000426	0.00158	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2A7—lung cancer	0.000424	0.00157	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—EP300—lung cancer	0.000422	0.00156	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTMR3—lung cancer	0.000419	0.00155	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—UGT1A1—lung cancer	0.000418	0.00155	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—AVP—lung cancer	0.000417	0.00155	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SDC4—lung cancer	0.000415	0.00153	CbGpPWpGaD
Bendroflumethiazide—Nausea—Doxorubicin—lung cancer	0.000409	0.000815	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—PGAM1—lung cancer	0.000408	0.00151	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2A7—lung cancer	0.000406	0.0015	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—MDM2—lung cancer	0.000405	0.0015	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000404	0.0015	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—RAF1—lung cancer	0.000403	0.00149	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GNG11—lung cancer	0.000403	0.00149	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SDC4—lung cancer	0.000398	0.00147	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2A7—lung cancer	0.000389	0.00144	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ALDOA—lung cancer	0.000383	0.00142	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SDC4—lung cancer	0.000381	0.00141	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—RRM1—lung cancer	0.000378	0.0014	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA3—lung cancer	0.000378	0.0014	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NCOA3—lung cancer	0.000372	0.00138	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—MMP1—lung cancer	0.000365	0.00135	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—RRM1—lung cancer	0.000362	0.00134	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ADCY1—lung cancer	0.000362	0.00134	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA3—lung cancer	0.000362	0.00134	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ABCG2—lung cancer	0.000362	0.00134	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ENO2—lung cancer	0.000355	0.00131	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—B4GALT5—lung cancer	0.000355	0.00131	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HPGDS—lung cancer	0.000355	0.00131	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PPP2R1B—lung cancer	0.000353	0.00131	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—APOA1—lung cancer	0.00035	0.00129	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—RRM1—lung cancer	0.000347	0.00128	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA3—lung cancer	0.000347	0.00128	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA4—lung cancer	0.000345	0.00128	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTT1—lung cancer	0.000344	0.00127	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2A6—lung cancer	0.00034	0.00126	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—B4GALT5—lung cancer	0.00034	0.00126	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GCLC—lung cancer	0.00034	0.00126	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA2—lung cancer	0.000337	0.00125	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA4—lung cancer	0.000331	0.00123	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—B4GALT5—lung cancer	0.000326	0.00121	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA1—lung cancer	0.000325	0.0012	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA2—lung cancer	0.000323	0.00119	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ENO1—lung cancer	0.000323	0.00119	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCC3—lung cancer	0.000321	0.00119	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—APOA1—lung cancer	0.000319	0.00118	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CG—lung cancer	0.000319	0.00118	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA4—lung cancer	0.000317	0.00118	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—EGF—lung cancer	0.000315	0.00117	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA1—lung cancer	0.000311	0.00115	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AKR1C1—lung cancer	0.000311	0.00115	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA2—lung cancer	0.000309	0.00115	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCC3—lung cancer	0.000308	0.00114	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—UGT1A1—lung cancer	0.000302	0.00112	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—TP53—lung cancer	0.000302	0.00112	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA1—lung cancer	0.000299	0.0011	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AKR1C1—lung cancer	0.000298	0.0011	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—CREBBP—lung cancer	0.000296	0.0011	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCC3—lung cancer	0.000295	0.00109	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GNG11—lung cancer	0.000291	0.00108	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—UGT1A1—lung cancer	0.000289	0.00107	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2E1—lung cancer	0.000289	0.00107	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NQO1—lung cancer	0.000286	0.00106	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AKR1C1—lung cancer	0.000286	0.00106	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CD—lung cancer	0.000281	0.00104	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GNG11—lung cancer	0.000279	0.00103	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—UGT1A1—lung cancer	0.000278	0.00103	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALDOA—lung cancer	0.000277	0.00103	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ALB—lung cancer	0.000277	0.00103	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—lung cancer	0.000276	0.00102	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CREBBP—lung cancer	0.00027	0.001	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOA3—lung cancer	0.000269	0.000996	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GNG11—lung cancer	0.000268	0.000991	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALDOA—lung cancer	0.000266	0.000984	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ADCY1—lung cancer	0.000262	0.000969	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCG2—lung cancer	0.000262	0.000969	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOA3—lung cancer	0.000258	0.000955	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—STK11—lung cancer	0.000258	0.000955	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ENO2—lung cancer	0.000257	0.00095	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HPGDS—lung cancer	0.000257	0.00095	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PPP2R1B—lung cancer	0.000255	0.000944	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALDOA—lung cancer	0.000255	0.000943	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ALB—lung cancer	0.000253	0.000936	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ADCY1—lung cancer	0.000251	0.000929	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCG2—lung cancer	0.000251	0.000929	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—RAF1—lung cancer	0.00025	0.000927	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTT1—lung cancer	0.000249	0.000922	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOA3—lung cancer	0.000247	0.000916	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HPGDS—lung cancer	0.000246	0.000911	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2A6—lung cancer	0.000246	0.000911	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ENO2—lung cancer	0.000246	0.000911	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GCLC—lung cancer	0.000246	0.000911	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PPP2R1B—lung cancer	0.000245	0.000905	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CB—lung cancer	0.000245	0.000905	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ADCY1—lung cancer	0.000241	0.000891	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCG2—lung cancer	0.000241	0.000891	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTP1—lung cancer	0.000239	0.000884	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTT1—lung cancer	0.000239	0.000884	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GCLC—lung cancer	0.000236	0.000873	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2A6—lung cancer	0.000236	0.000873	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ENO2—lung cancer	0.000236	0.000873	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HPGDS—lung cancer	0.000236	0.000873	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PPP2R1B—lung cancer	0.000234	0.000868	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ENO1—lung cancer	0.000233	0.000864	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CAT—lung cancer	0.000232	0.00086	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTT1—lung cancer	0.000229	0.000847	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—RAF1—lung cancer	0.000229	0.000847	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GCLC—lung cancer	0.000226	0.000837	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2A6—lung cancer	0.000226	0.000837	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ABCB1—lung cancer	0.000226	0.000836	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IL2—lung cancer	0.000225	0.000831	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ENO1—lung cancer	0.000224	0.000828	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—HRAS—lung cancer	0.000222	0.000822	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TYMS—lung cancer	0.000222	0.000822	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTM1—lung cancer	0.000219	0.000812	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ENO1—lung cancer	0.000214	0.000794	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2E1—lung cancer	0.000209	0.000775	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP1A1—lung cancer	0.000208	0.00077	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NQO1—lung cancer	0.000207	0.000766	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ERCC2—lung cancer	0.000206	0.000763	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—EP300—lung cancer	0.000202	0.000746	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2E1—lung cancer	0.000201	0.000743	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NQO1—lung cancer	0.000198	0.000734	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SRC—lung cancer	0.000196	0.000725	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2E1—lung cancer	0.000192	0.000712	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—VEGFA—lung cancer	0.000191	0.000707	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NQO1—lung cancer	0.00019	0.000704	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—NRAS—lung cancer	0.000189	0.000698	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—STK11—lung cancer	0.000187	0.00069	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—MAPK3—lung cancer	0.000181	0.000668	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—STK11—lung cancer	0.000179	0.000662	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—APOA1—lung cancer	0.000178	0.00066	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTP1—lung cancer	0.000173	0.000639	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—STK11—lung cancer	0.000171	0.000635	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CAT—lung cancer	0.000168	0.000622	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTP1—lung cancer	0.000165	0.000612	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCB1—lung cancer	0.000163	0.000605	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CG—lung cancer	0.000163	0.000603	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—KRAS—lung cancer	0.000162	0.000601	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CAT—lung cancer	0.000161	0.000596	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TYMS—lung cancer	0.00016	0.000594	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTP1—lung cancer	0.000159	0.000587	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTM1—lung cancer	0.000159	0.000587	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCB1—lung cancer	0.000157	0.00058	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—POMC—lung cancer	0.000155	0.000574	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CAT—lung cancer	0.000154	0.000571	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TYMS—lung cancer	0.000154	0.000569	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTM1—lung cancer	0.000152	0.000563	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CREBBP—lung cancer	0.000151	0.000559	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP1A1—lung cancer	0.00015	0.000557	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCB1—lung cancer	0.00015	0.000556	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ERCC2—lung cancer	0.000149	0.000552	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CA—lung cancer	0.000149	0.000552	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TYMS—lung cancer	0.000147	0.000546	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTM1—lung cancer	0.000146	0.00054	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TP53—lung cancer	0.000144	0.000534	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP1A1—lung cancer	0.000144	0.000534	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CD—lung cancer	0.000143	0.00053	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ERCC2—lung cancer	0.000143	0.000529	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ALB—lung cancer	0.000141	0.000523	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP1A1—lung cancer	0.000138	0.000512	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—HRAS—lung cancer	0.000138	0.000511	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ERCC2—lung cancer	0.000137	0.000507	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—APOA1—lung cancer	0.000129	0.000477	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CB—lung cancer	0.000125	0.000462	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—APOA1—lung cancer	0.000124	0.000458	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTGS2—lung cancer	0.000124	0.000458	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—AKT1—lung cancer	0.000122	0.000451	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—APOA1—lung cancer	0.000119	0.000439	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CG—lung cancer	0.000118	0.000436	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CG—lung cancer	0.000113	0.000418	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—POMC—lung cancer	0.000112	0.000415	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CREBBP—lung cancer	0.000109	0.000404	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CG—lung cancer	0.000108	0.000401	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTEN—lung cancer	0.000108	0.000399	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—POMC—lung cancer	0.000107	0.000398	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CREBBP—lung cancer	0.000105	0.000387	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CD—lung cancer	0.000104	0.000383	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—POMC—lung cancer	0.000103	0.000381	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—EP300—lung cancer	0.000103	0.000381	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALB—lung cancer	0.000102	0.000378	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CREBBP—lung cancer	0.0001	0.000372	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CD—lung cancer	9.93e-05	0.000367	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALB—lung cancer	9.8e-05	0.000363	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CD—lung cancer	9.52e-05	0.000352	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALB—lung cancer	9.39e-05	0.000348	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CB—lung cancer	9.02e-05	0.000334	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTGS2—lung cancer	8.94e-05	0.000331	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CB—lung cancer	8.65e-05	0.00032	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTGS2—lung cancer	8.57e-05	0.000317	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CB—lung cancer	8.29e-05	0.000307	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTGS2—lung cancer	8.22e-05	0.000304	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTEN—lung cancer	7.8e-05	0.000289	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CA—lung cancer	7.61e-05	0.000282	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTEN—lung cancer	7.48e-05	0.000277	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—EP300—lung cancer	7.44e-05	0.000275	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTEN—lung cancer	7.17e-05	0.000265	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—EP300—lung cancer	7.13e-05	0.000264	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—EP300—lung cancer	6.84e-05	0.000253	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AKT1—lung cancer	6.22e-05	0.00023	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CA—lung cancer	5.5e-05	0.000204	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CA—lung cancer	5.27e-05	0.000195	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CA—lung cancer	5.06e-05	0.000187	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AKT1—lung cancer	4.49e-05	0.000166	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AKT1—lung cancer	4.31e-05	0.000159	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AKT1—lung cancer	4.13e-05	0.000153	CbGpPWpGaD
